Sawyer M H, Inchauspe G, Biron K K, Waters D J, Straus S E, Ostrove J M
Medical Virology Section, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
J Gen Virol. 1988 Oct;69 ( Pt 10):2585-93. doi: 10.1099/0022-1317-69-10-2585.
The pyrimidine deoxyribonucleoside kinase (dPK) genes from five wild-type and four acyclovir-resistant varicella-zoster virus (VZV) strains were studied. One of the acyclovir-resistant strains was isolated from a patient receiving chronic acyclovir therapy. Acyclovir-resistant strains expressed the 1.8 kb VZV dPK transcript but lacked dPK activity. To determine the basis for the lack of enzyme activity the dPK gene from each strain was cloned and its DNA sequence determined. The VZV dPK gene was found to be highly conserved among strains, with greater than 99% nucleotide and amino acid homology. Each acyclovir-resistant VZV strain differed from its wild-type parent in only a single amino acid. The dPK genes from the acyclovir-resistant strains contained either point mutations near the putative thymidine-binding site of the enzyme or ones that resulted in the premature termination of protein synthesis. Single point mutations were sufficient to render these strains dPK-negative and highly resistant to acyclovir. The molecular basis for acyclovir resistance at the dPK locus of VZV is similar to that previously noted to render herpes simplex viruses resistant to acyclovir.
对来自5株野生型和4株耐阿昔洛韦水痘带状疱疹病毒(VZV)毒株的嘧啶脱氧核糖核苷激酶(dPK)基因进行了研究。其中一株耐阿昔洛韦毒株是从一名接受慢性阿昔洛韦治疗的患者中分离出来的。耐阿昔洛韦毒株表达1.8 kb的VZV dPK转录本,但缺乏dPK活性。为了确定缺乏酶活性的原因,对每个毒株的dPK基因进行了克隆并测定了其DNA序列。发现VZV dPK基因在毒株间高度保守,核苷酸和氨基酸同源性均大于99%。每株耐阿昔洛韦的VZV毒株与其野生型亲本仅在一个氨基酸上存在差异。耐阿昔洛韦毒株的dPK基因要么在该酶假定的胸苷结合位点附近存在点突变,要么存在导致蛋白质合成提前终止的突变。单点突变足以使这些毒株dPK呈阴性并对阿昔洛韦高度耐药。VZV在dPK位点对阿昔洛韦耐药的分子基础与之前观察到的使单纯疱疹病毒对阿昔洛韦耐药的分子基础相似。